<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>pioglitazone</title><link>http://www.unboundmedicine.com/medline/ebm/research/pioglitazone</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Pioglitazone Improves Metabolic Markers in Patients with Type 2 Diabetes Independently from Physical Activities: Results from the IRIS III Study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19885350/full_citation/Pioglitazone_Improves_Metabolic_Markers_in_Patients_with_Type_2_Diabetes_Independently_from_Physical_Activities:_Results_from_the_IRIS_III_Study_</link><description>Schöndorf T, Pfützner A, Lübben G, et al. <br/><span class="title">Pioglitazone Improves Metabolic Markers in Patients with Type 2 Diabetes Independently from Physical Activities: Results from the IRIS III Study. [Journal Article]</span><br/><span class="source" title="Journal of diabetes science and technology (Online)">J Diabetes Sci Technol 2008 Mar; 2(2):244-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19885350/abstract/Pioglitazone_Improves_Metabolic_Markers_in_Patients_with_Type_2_Diabetes_Independently_from_Physical_Activities:_Results_from_the_IRIS_III_Study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19885350/full_citation/Pioglitazone_Improves_Metabolic_Markers_in_Patients_with_Type_2_Diabetes_Independently_from_Physical_Activities:_Results_from_the_IRIS_III_Study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19885350/Pioglitazone_Improves_Metabolic_Markers_in_Patients_with_Type_2_Diabetes_Independently_from_Physical_Activities:_Results_from_the_IRIS_III_Study_">Find Related Articles</a> </description></item><item><title>A Comparison of the Role of PPAR and RAR on CYP26 Regulation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884280/full_citation/A_Comparison_of_the_Role_of_PPAR_and_RAR_on_CYP26_Regulation_</link><description>Tay S, Dickmann L, Dixit V, et al. <br/><span class="title">A Comparison of the Role of PPAR and RAR on CYP26 Regulation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular pharmacology">Mol Pharmacol 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884280/abstract/A_Comparison_of_the_Role_of_PPAR_and_RAR_on_CYP26_Regulation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884280/full_citation/A_Comparison_of_the_Role_of_PPAR_and_RAR_on_CYP26_Regulation_">Full Citation</a></description></item><item><title>Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879669/full_citation/Identification_of__beta_carboxyethyl__rhodanine_derivatives_exhibiting_peroxisome_proliferator_activated_receptor_gamma_activity_</link><description>Choi J, Ko Y, Lee HS, et al. <br/><span class="title">Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of medicinal chemistry">Eur J Med Chem 2009 Oct 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879669/abstract/Identification_of__beta_carboxyethyl__rhodanine_derivatives_exhibiting_peroxisome_proliferator_activated_receptor_gamma_activity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879669/full_citation/Identification_of__beta_carboxyethyl__rhodanine_derivatives_exhibiting_peroxisome_proliferator_activated_receptor_gamma_activity_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19879669/Identification_of__beta_carboxyethyl__rhodanine_derivatives_exhibiting_peroxisome_proliferator_activated_receptor_gamma_activity_">Find Related Articles</a> </description></item><item><title>Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19878646/full_citation/Impact_of_DNA_demethylation_of_the_G0S2_gene_on_the_transcription_of_G0S2_in_squamous_lung_cancer_cell_lines_with_or_without_nuclear_receptor_agonists_</link><description>Kusakabe M, Watanabe K, Emoto N, et al. <br/><span class="title">Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists. [JOURNAL ARTICLE]</span><br/><span class="source" title="Biochemical and biophysical research communications">Biochem Biophys Res Commun 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19878646/abstract/Impact_of_DNA_demethylation_of_the_G0S2_gene_on_the_transcription_of_G0S2_in_squamous_lung_cancer_cell_lines_with_or_without_nuclear_receptor_agonists_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19878646/full_citation/Impact_of_DNA_demethylation_of_the_G0S2_gene_on_the_transcription_of_G0S2_in_squamous_lung_cancer_cell_lines_with_or_without_nuclear_receptor_agonists_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19878646/Impact_of_DNA_demethylation_of_the_G0S2_gene_on_the_transcription_of_G0S2_in_squamous_lung_cancer_cell_lines_with_or_without_nuclear_receptor_agonists_">Find Related Articles</a> </description></item><item><title>Effect of Pioglitazone on Visfatin Expression in 3T3-L1 Adipocytes and SD Rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19878073/full_citation/Effect_of_Pioglitazone_on_Visfatin_Expression_in_3T3_L1_Adipocytes_and_SD_Rats_</link><description>Lv Q, Wang Y, Wang W, et al. <br/><span class="title">Effect of Pioglitazone on Visfatin Expression in 3T3-L1 Adipocytes and SD Rats. [Journal Article]</span><br/><span class="source" title="Endocrine research">Endocr Res 2009; 34(4):130-41.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19878073/abstract/Effect_of_Pioglitazone_on_Visfatin_Expression_in_3T3_L1_Adipocytes_and_SD_Rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19878073/full_citation/Effect_of_Pioglitazone_on_Visfatin_Expression_in_3T3_L1_Adipocytes_and_SD_Rats_">Full Citation</a></description></item><item><title>Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19875376/full_citation/Effects_of_pioglitazone_on_subclinical_atherosclerosis_and_insulin_resistance_in_nondiabetic_renal_allograft_recipients_</link><description>Han SJ, Hur KY, Kim YS, et al. <br/><span class="title">Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients. [JOURNAL ARTICLE]</span><br/><span class="source" title="Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association">Nephrol Dial Transplant 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19875376/abstract/Effects_of_pioglitazone_on_subclinical_atherosclerosis_and_insulin_resistance_in_nondiabetic_renal_allograft_recipients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19875376/full_citation/Effects_of_pioglitazone_on_subclinical_atherosclerosis_and_insulin_resistance_in_nondiabetic_renal_allograft_recipients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19875376/Effects_of_pioglitazone_on_subclinical_atherosclerosis_and_insulin_resistance_in_nondiabetic_renal_allograft_recipients_">Find Related Articles</a> </description></item><item><title>Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19864959/full_citation/Potentiation_by_candesartan_of_protective_effects_of_pioglitazone_against_type_2_diabetic_cardiovascular_and_renal_complications_in_obese_mice_</link><description>Fukuda M, Nakamura T, Kataoka K, et al. <br/><span class="title">Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of hypertension">J Hypertens 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19864959/abstract/Potentiation_by_candesartan_of_protective_effects_of_pioglitazone_against_type_2_diabetic_cardiovascular_and_renal_complications_in_obese_mice_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19864959/full_citation/Potentiation_by_candesartan_of_protective_effects_of_pioglitazone_against_type_2_diabetic_cardiovascular_and_renal_complications_in_obese_mice_">Full Citation</a></description></item><item><title>Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19864452/full_citation/Saxagliptin_Added_to_a_Thiazolidinedione_Improves_Glycemic_Control_in_Patients_with_Type_2_Diabetes_and_Inadequate_Control_on_Thiazolidinedione_Alone_</link><description>Hollander P, Li J, Allen E, et al. <br/><span class="title">Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of clinical endocrinology and metabolism">J Clin Endocrinol Metab 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19864452/abstract/Saxagliptin_Added_to_a_Thiazolidinedione_Improves_Glycemic_Control_in_Patients_with_Type_2_Diabetes_and_Inadequate_Control_on_Thiazolidinedione_Alone_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19864452/full_citation/Saxagliptin_Added_to_a_Thiazolidinedione_Improves_Glycemic_Control_in_Patients_with_Type_2_Diabetes_and_Inadequate_Control_on_Thiazolidinedione_Alone_">Full Citation</a> | <a href="http://jcem.endojournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19864452">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19864452/Saxagliptin_Added_to_a_Thiazolidinedione_Improves_Glycemic_Control_in_Patients_with_Type_2_Diabetes_and_Inadequate_Control_on_Thiazolidinedione_Alone_">Find Related Articles</a> </description></item><item><title>Peroxisome proliferator-activated receptor gamma (PPAR{gamma}) regulates the expression and Function of very low density lipoprotein receptor.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19861583/full_citation/Peroxisome_proliferator_activated_receptor_gamma__PPAR{gamma}__regulates_the_expression_and_Function_of_very_low_density_lipoprotein_receptor_</link><description>Tao H, Aakula S, Abumrad NN, et al. <br/><span class="title">Peroxisome proliferator-activated receptor gamma (PPAR{gamma}) regulates the expression and Function of very low density lipoprotein receptor. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of physiology. Endocrinology and metabolism">Am J Physiol Endocrinol Metab 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19861583/abstract/Peroxisome_proliferator_activated_receptor_gamma__PPAR{gamma}__regulates_the_expression_and_Function_of_very_low_density_lipoprotein_receptor_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19861583/full_citation/Peroxisome_proliferator_activated_receptor_gamma__PPAR{gamma}__regulates_the_expression_and_Function_of_very_low_density_lipoprotein_receptor_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19861583/Peroxisome_proliferator_activated_receptor_gamma__PPAR{gamma}__regulates_the_expression_and_Function_of_very_low_density_lipoprotein_receptor_">Find Related Articles</a> </description></item><item><title>Effects of Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19858066/full_citation/Effects_of_Pioglitazone_a_Peroxisome_Proliferator_Activated_Receptor_Gamma_Agonist_on_the_Urine_and_Urothelium_of_the_Rat_</link><description>Suzuki S, Arnold LL, Pennington KL, et al. <br/><span class="title">Effects of Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat. [JOURNAL ARTICLE]</span><br/><span class="source" title="Toxicological sciences : an official journal of the Society of Toxicology">Toxicol Sci 2009 Oct 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19858066/abstract/Effects_of_Pioglitazone_a_Peroxisome_Proliferator_Activated_Receptor_Gamma_Agonist_on_the_Urine_and_Urothelium_of_the_Rat_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19858066/full_citation/Effects_of_Pioglitazone_a_Peroxisome_Proliferator_Activated_Receptor_Gamma_Agonist_on_the_Urine_and_Urothelium_of_the_Rat_">Full Citation</a></description></item></channel></rss>